Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,108
Recruiting: 10,888
Ph III recruiting: 1,278
Growth YoY: +12.8%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,158)

clinicaltrialsPublishedShowing 51–100 of 645 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04272086	Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy	completed	Phase 4	140	Icahn School of Medicine at Mount SinaiOTHER	1	Nov 12, 2025	clinicaltrials
NCT06218823	Tobacco Treatment Comparison for Cancer Care	completed	Phase 4	52	University of Wisconsin, MadisonOTHER	1	Oct 27, 2025	clinicaltrials